Benzamide

Benzamide

SCHEMBL423609

COc1cc2c(NC(=O)c3c(Br)ccc4c3OCO4)ccc(-c3ccc(-c4ccccc4)cc3)c2cc1OC.NC(=O)c1ccccc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
LMNA P02545 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 2/20 0.42
TSHR P16473 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 1/20 0.42
RXFP1 Q9HBX9 1/20 0.38
ABCB1 P08183 4/20 0.37
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ABCC1 P33527 1/20 0.36
TP53 P04637 2/20 0.36
PKM P14618 1/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL420470 0.94 MAPT (0.44) MAPTNPC1RAB9ALMNASMN1; SMN2
Benzamide SCHEMBL424272 0.83 NPSR1 (0.37) MAPTKDM4EHPGDTP53HTT
SCHEMBL10132597 0.80 RXFP1 (0.45) MAPTNPC1RAB9ALMNASMN1; SMN2
SCHEMBL10132615 0.78 RXFP1 (0.46) MAPTNPC1RAB9ALMNASMN1; SMN2
SCHEMBL13284140 0.77 LMNA (0.46) MAPTLMNAKDM4EALDH1A1ABCB1
SCHEMBL419335 0.77 NPSR1 (0.38) MAPTNPC1RAB9ALMNAKDM4E
SCHEMBL10132867 0.77 MAPT (0.47) MAPTNPC1RAB9ALMNASMN1; SMN2
SCHEMBL10132854 0.76 LMNA (0.41) MAPTLMNASMN1; SMN2KDM4EALDH1A1
SCHEMBL10162989 0.75 LMNA (0.47) MAPTLMNAKDM4EALDH1A1TSHR
SCHEMBL10132734 0.74 ALDH1A1 (0.44) MAPTNPC1RAB9ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
EP-2387564-A1 BENZO ÝC¨PHENANTHRIDINES AS ANTIMICROBIAL AGENTS Rutgers, The State University of New Jersey (US) 2011-11-23 EP disclosed
US-8037884-B2 Modular system for patient positioning during medical procedures ALLEN MEDICAL SYSTEMS, INC. (US) 2011-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH MAPT 4875/4885NPC1 2668/4885RAB9A 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.